LifeGoal Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
5,618
-1,206
-18% -$69.3K 0.15% 93
2026
Q1
$421K Buy
+6,824
New +$398K 0.24% 61

Other funds holding BMY

LifeGoal Wealth Advisors's BMY Position: Q2 2026 in Review

LifeGoal Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, selling an estimated $69.3K and leaving 5,618 shares worth $324K. The position accounts for 0.15% of the portfolio, ranked #93.

LifeGoal Wealth Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $421K in Q1 2026. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • LifeGoal Wealth Advisors held 5,618 shares of Bristol-Myers Squibb worth $324K as of Q2 2026.
  • LifeGoal Wealth Advisors sold 1,206 Bristol-Myers Squibb shares in Q2 2026, an estimated $69.3K.
  • Bristol-Myers Squibb made up 0.15% of LifeGoal Wealth Advisors's portfolio in Q2 2026, its #93 holding.
  • LifeGoal Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • LifeGoal Wealth Advisors's Bristol-Myers Squibb position peaked at $421K in Q1 2026.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on LifeGoal Wealth Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.